FIELD: medicine. SUBSTANCE: method involves intravenously administering Carboplatin at a dose of 0.05 mg/kg of body weight once per 3 weeks. The total treatment is 2 to 6 courses long achieving complete focus resorption or reduced tumor prominence to 6 mm and tumor base to 10-14 mm. EFFECT: reduced frequency and severity degree of complication. 4 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR VISUAL FUNCTIONS STATE PREDICTION FOR CHILDREN WITH RETINOBLASTOMA AT BACKGROUND OF SYSTEMIC CHEMOTHERAPY | 2016 |
|
RU2624391C1 |
| METHOD OF TREATING UVEAL MELANOMA | 2000 |
|
RU2169006C1 |
| METHOD FOR EARLY DIAGNOSTICS OF OPTICAL NEUROPATHY AGAINST THE BACKGROUND OF SYSTEMATIC OR COMBINED CHEMOTHERAPY IN CHILDREN WITH RETINOBLASTOMA | 2020 |
|
RU2750153C1 |
| METHOD FOR TREATING AND PREVENTING MALIGNANT LYMPHOMA OF CONJUNCTIVA USING BETA-APPLICATION THERAPY | 2000 |
|
RU2164161C1 |
| METHOD OF DIAGNOSING SMALL RETINOBLASTOMA IN CHILDREN | 2023 |
|
RU2799256C1 |
| METHOD OF ASSESSING EFFICIENCY OF COMBINED ORGAN-PRESERVING TREATMENT OF PRIMARY INITIAL RETINOBLASTOMA IN CHILDREN | 2012 |
|
RU2486859C1 |
| DIAGNOSTIC TECHNIQUE FOR RETINOBLASTOMA IN CHILDREN | 2010 |
|
RU2440017C1 |
| METHOD FOR PREDICTING UVEITIC MELANOMA CLINICAL COURSE | 1999 |
|
RU2149404C1 |
| METHOD OF THERAPEUTIC APPROACH SELECTION AT INITIAL STAGE OF RETINOBLASTOMA IN CHILDREN | 2018 |
|
RU2673860C1 |
| METHOD FOR TREATING HEMORRHAGES INTO INTERNAL MEDIA AND MEMBRANES OF AN EYE ACCOMPANIED WITH BLOOD PLATELETS HYPERAGGREGATION | 1998 |
|
RU2161020C2 |
